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a b s t r a c t
Kawasaki disease (KD) is an autoimmune disease in which the medium-sized blood vessels throughout
the body become inﬂamed. The increased evidences showed that TNF- was association with vascular
inﬂammation in KDpatients. However the detailedmechanismwas still unclear. Recent studies indicated
abnormal expressed longnon-codingRNAs (LncRNAs) involved inmanydiseases. Thus thepurpose of this
study is to explore the role of lncRNAs in KD and ﬁnd out the new target for KD treatment. In this study,
ﬁrstly we veriﬁed the overexpressed TNF- in KD patients, and found TNF-was able to induce HUVECs
apoptosis and inhibitHUVECsproliferation.After thiswe screenedoutpregnancy inducednoncodingRNA
(PINC) was signiﬁcantly overexpression in TNF- treated HUVECs. We also found PINC overexpressed inNF-
ong non-coding RNAs
regnancy induced noncoding RNA
poptosis
KD patients. For further study, we designed two siRNA of PINC. After silenced the expression of PINC in
HUVECs, we found the Knockdown of PINC enhanced the viability of HUVECs treated with TNF-, and
increased the expression of anti-apoptotic and reduced the expression of apoptotic gene. These results
suggest PINC involves in the process of TNF- induces vascular endothelial cell apoptosis, it may become
a new target for KD treatment.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND. Introduction
Kawasaki disease (KD), also deﬁned as Kawasaki syndrome,
ucocutaneous lymph node syndrome and lymph node syndrome
Burns et al., 2000), was ﬁrst found in 1967 by Tomisaku Kawasaki
n Japan (Kawasaki, 1967). Itwasusually occurred in childrenunder
ve years old. And it had been identiﬁed that it was able to affect
any organ systems (e.g. blood vessels, skin, mucous membranes,
nd lymph nodes). Specially, the rarest but most severe conse-
uencewas on the heart, where it could cause fatal coronary artery
neurysms in untreated children. It have seriously affected the life
f the sick children.However, thedetailedpathogenesis is not clear,
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E-mail address: xianmei huang@126.com (X. Huang).
1 These authors contributed equally to this work.
ttp://dx.doi.org/10.1016/j.biocel.2016.01.011
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/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
the study of pathogenesis of KD will contribute to ﬁnd out new
therapeutic targets.
It is well known that KD is an autoimmune disease with char-
acterization of the medium-sized blood vessels throughout the
body become inﬂamed. The previous studies showed the expres-
sion of TNF-was increased in KD patients (Furuya et al., 2004; Tan
et al., 2013). TNF- is one kind of inﬂammatory cytokines, which
secreted by monocytes and macrophages, and plays an important
role in inﬂammatory response, cells’ proliferation and apoptosis
(Federici et al., 2005; Mylroie et al., 2015). It can induce inﬂam-
matory response of vascular smooth muscle cell via activating
the expression of downstream inﬂammatory genes through NF-
B (Nallasamy et al., 2014). Although increased evidences have
demonstrated TNF- can induce vascular inﬂammation, themech-
anism is unclear.
Long non-coding RNAs (LncRNAs) are non-protein coding
transcripts longer than 200 nucleotides (Perkel, 2013). Recent
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Table 1
The primer sequences of apoptotic related genes.
Name Forward Reverse
Cyclin D1 CAAGGCCTGAACCTGAGGAG CTTGGGGTCCATGTTCTGCT
Caspase-3 GGGGAAATGGCTCATCCACA ATGTTGTCTTCTGGGCGGAG
c-FLIP GAGTGCCGGCTATTGGACTT GCGCTTCTCTCCTACACCTC
Caspase-7 CGTGGGAACGGCAGGAAGT CGGGTGGTCTTGATGGATCGC. Jiang et al. / The International Journal of
ecognition that lncRNAs function in various aspects of cell biology
as focused increasing attention on their potential to contribute
oward disease etiology. Many association studies have iden-
iﬁed lncRNAs that are aberrantly expressed in disease states.
or example, in prostate tumors, lncRNAs-PCGEM1, is correlated
ith increased proliferation and colony formation suggesting an
nvolvement in regulating cell growth (Fu et al., 2006). In addition
ocancer, lncRNAsalsoexhibit aberrant expression inotherdisease.
verexpression of PRINS is associated with psoriasis susceptibility
Sonkoly et al., 2005). It suggests lncRNAs may as a new target for
athogenesis study.
According to the aforementioned, in this study, we want to
xplore the role of lncRNAs in KD, and screen out the differentiated
xpressed lncRNAs. After the differentiated expressed lncRNAs are
creened out, the functions of these lncRNAs are further veriﬁed.
. Materials and methods
.1. Cell culture
In this study, we used human umbilical vascular endothelial
ells (HUVECs) asvascular inﬂammationmodelofKD.HUVECswere
btained from Cambrex (Walkersville, MD, USA). Cells were cul-
ured in M199 medium containing 10% fetal bovine serum (FBS,
nvitrogen), bovine endothelial cell growth supplement (20ng/ml),
eparin (4/mL), and 1% of penicillin/streptomycin solution (Invi-
rogen) at 37 ◦C in a humidiﬁed 5% CO2 environment.
.2. Patients
In this study, we collected 4 KD patients in Hangzhou First Peo-
le’s Hospital from January 2014 to March 2015, 3 males, 1 female.
heminimumonset age is 10months, and themaximumonset age
s 31months. The average age is 1.9±1.17 years old. These patients
id not accept speciﬁc treatment such as r-globulin or hormone.
.3. ELISA
The serums of KD patients were obtained from Afﬁliated
angzhou Hospital of Nanjing Medical University, Hangzhou First
eople’s Hospital, then the secretion level of TNF- was evalu-
ted by ELISA using an Invitrogen kit (Invitrogen) according to the
anufacturer’s protocol. After the reaction, a value at wavelength
f 450nm was measured with enzyme-linked spectrophotometer,
nd the concentration of TNF- was calculated from the standard
urve. All analyses weremade in duplicate and themean valuewas
sed for statistical analysis.
.4. RT-PCR
HUVECs were seeded into 6-well plates and incubated for 24h,
hen DMSO, TNF-, TNF- in combination with siRNA were added
espectively and continued cultured for 24h. Thereafter, total RNA
solation and cDNA synthesis were conducted using TRIzol and
ligo dT (Invitrogen) according to the standard procedures. Brieﬂy,
rst-strand cDNA was reverse-transcribed from 1g total RNA
sing the Super-Script First-Strand cDNA System (Invitrogen), and
as ampliﬁed by Platinum SYBR Green qPCR SuperMix-UDG (Invi-
rogen). A master mix was prepared for each PCR reaction, which
ncluded Platinum SYBR Green qPCR SuperMix-UDG, forward
rimer, reverse primer, and 10ng of template cDNA. Ampliﬁcation
onditionswere as follows: hold at 95 ◦C for 10min, followed by 40
ycles at 15 s at 95 ◦C and 1min in 60 ◦C. Thermal cycling and ﬂu-
rescence detection were done using the StepOnePlusTM real-timeBcl-2 GAACTGGGGGAGGATTGTGG CATCCCAGCCTCCGTTATCC
Bax CAGAGGCGGGGGATGATTG TGTCCAGCCCATGATGGTTC
TNF- CTGGGCAGGTCTACTTTGGG CTGGAGGCCCCAGTTTGAAT
PCR System (Applied Biosystems, USA). The primers were used as
showing in Table 1.
2.5. Apoptosis assay
Apoptosis was measured using an Annexin V/ﬂuorescein
isothiocyanate (FITC) apoptosis detection kit (Beyotime biotech
company, China). After HUVECswere treatedwith DMSO, 50ng/ml
TNF-, 500ng/ml TNF- for 24h, cells were harvested after indi-
cated treatments with trypsin (0.25%) and a single cell suspension
prepared. Cells were then washed with PBS and pelleted by cen-
trifugation at 1000 rpm for 5min. Cells were resuspended in
binding buffer and the cell densitywas adjusted to 5×105 cells/ml.
A 95-L aliquot of the cell suspension was added to 5L
Annexin-V-FITC, and then cells were incubated for 10min at room
temperature in the dark. The suspension was then washed with
PBS and resuspended in 190L binding buffer before adding 10L
propidium iodide (PI) to obtain a ﬁnal concentration of 1g/mL.
Finally the samples were examined by ﬂow cytometry (BD FACS
Vantage; BD Sciences, San Jose, CA, USA).
2.6. CCK-8 assay
A total of 5000 HUVECs were plated into each well of a 96-
well plate and cultured for 24h. After this the culture medium was
added with DMSO, 50ng/ml TNF- and 500ng/ml TNF- respec-
tively, then the cells were cultured for 1 and 3 days. Subsequently,
10L of CCK-8 was added to each well and incubated for 3h, and
a microplate reader was used to detect absorbance at 450nm.
2.7. Western blot
HUVECs were seeded into 6-well plates and incubated for 24h,
after this DMSO and 500ng/ml TNF- were added respectively
and continued cultured for 24h. Then cells were harvested by
scraping from the wells, proteins were obtained by homogeniz-
ing HUVECs with mammalian protein extraction (Nacalai Tesque,
Kyoto, Japan), and the protein concentrations were determined
using Coomassie protein reagent (Bio-Rad, CA). Twenty-ﬁvemicro-
grams of protein was loaded per lane and separated by SDS–PAGE
(10%), then transferred to nitrocellulose membranes (Amersham,
Arlington Heights, IL) and blocked overnight in Tris-buffered saline
containing 0.1% Tween and 5% skim milk. After this the mem-
brane was incubated with primary antibodies Cyclin-D1 (1:1000;
cat. no. sc-70899; Santa Cruz Biotechnology, Inc., Dallas, TX, USA),
C-ﬂip (1:100; cat. no. PA5-19899; ThermoFisher Scientiﬁc, USA),
Caspase-7 (1:800, cat. no.sc-56063; Santa Cruz), Bcl-2 (1:1000; cat.
no. sc-492; Santa Cruz), Caspase-3 (1:800; cat. no. sc-65496; Santa
Cruz), Bax (1:100; cat. no.MA5-14000; ThermoFisher Scientiﬁc),-
actin (1:1000; cat. no. A2668; Sigma–Aldrich, St. Louis, MO, USA),
GAPDH (1:1000; cat. no. G9295; Sigma–Aldrich, St. Louis,MO, USA)
at 4 ◦C and subsequently incubated with a secondary antibody for
one hour at room temperature. The detection of speciﬁc proteins
was carried out with an ECL Western blotting kit according to the
recommended procedure.
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Table 2
The primer sequences of lncRNAs which were studied in this study.
ID LncRNA name Forward (5′ to 3′) Reverse (5′ to 3′)
1 7SK AAACAAGCTCTCAAGGTC AAACAAGCTCTCAAGGTC
2 7SL CTTGAGTCCAGGAGTTCT CACCATATTGATGCCGAA
3 anti-NOS2A TGGACTATATTCACTACAC TAACTCAGCATTATTACTTG
4 A130040M12Rik TTGAACCAGACGAACAGA AAGAGAAGAGAAGAGAAGAGAA
5 AIR AACCTTCTCTTCATTCAG GAACCTTATAGTCTCAATCT
6 AK023948 AACAGCATTATTTCTACC TTCCTTCTCTTCTTATCA
7 ASFMR1 ACAGGATGGCTAATAACAA ACAAGGATGAACACAGAA
8 ATP6V1G2-DDX39B ATGAGAATGATGCCAAGAT ACTGTAGGAGGAGATGTC
9 ATXN8OS CATTACTGTGTAGCAATAC AATTCAAGCCATTAACCT
10 BACE1-AS CCTCAGTTCCTTCATCTCTA TTACCAAGTGCCTTCTCT
11 BCAR4 ATCTTGAGTTGTTGCCATTA GACCAGGTGATAGGAGTT
12 BCYRN1 CTGGGCAATATAGCGAGAC TGCTTTGAGGGAAGTTACG
13 BDNF-AS1 CCTTGTGTTATCTGTTGT ATACTCTGGTTGGTGTTA
14 BOK-AS1 AATACCACCAGTCTCATA GTCATAGCAGATAGAAGTT
15 BPESC1 GCAGATGATAACACTATT TATGATACTACCAACCTT
16 C15orf2 CAATAGACGCTAATAGGA AAGTGCTGAGATTATAGG
17 C15orf2 CACTACTATGGACAAGAA AAGGATAATGCTGGTATT
18 C1QTNF9B-AS1 TTAACTCGTCTCGCTTCA AACTCCTCTCACCATCTAC
19 CASC2 TTCTAATCCTGGTTCTACA CAATAATCTCTGCTTCTCA
20 CBR3-AS1 AATCTGTGCCTTGTATTCATAT TGTCAATCCTGTCAGTATCA
21 CDKN2B-AS1 AAGGTAGTATGTTGTGCTA ATAACGATGCTTCAGTCA
22 CECR3 CCTCATCTCCACTATCTC GGTTGTCACATCATTAAGT
23 CECR9 TTCATCAACTTCATTCCTG CTCTTAGTCAGCCTCTTG
24 CHL1-AS2 CAGAGTCTATAATGTTACCA GATTCATAAGGCATCAGA
25 CRNDE AGAGACACAACACCAACA CAAGACAGCCTTATCAATCAT
26 CUDR TTCCTTATTATCTCTTCTG TCCATCATACGAATAGTA
27 DAOA-AS1 CCATAATGTTCTTGACCACTT CACTTCCAACCTCTTCCA
28 DAPK1 ATGATGCTGATGCTGATA ATTCTAACAACACTCTACCA
29 DGCR5 CCAACTGTCCGTTCACTT CCTGGCTCAGAAGAGAATC
30 DISC2 GACGAAGAAGAATGAAGAA AATGCCATATTACCTTGATT
31 DLEU1 CTGCCTAGAGTTAATGAT AAGTTAAGACGGTAAGAG
32 DLEU2 TGTCCGTAGCATATAACTG CTATCTTCACTGTCCTTCTAA
33 DLG2AS CACTCTATCATCATACACTAA GTCTCTTACCTTCACTTG
34 DMPK AGGACTTCAGAACTTGGA TAGGATTACAGGCGTGAG
35 DNM3OS ATAGAGCAAGTCTGGATT GGATGAGGCAATAACATT
36 DSCAM-AS1 TCTCAATTCTTGTGATTCT AGTGTTAGAGCAATAGTG
37 EPB41L4A-AS1 TGCTGATACTTCCTGAGA GGTAATATGCCTGCGATT
38 ESRG TCTCCATACCACTCCACAA CTGACATTCCTGCCTTCTT
39 EVF AAGCAATAGAATGGTGATT CAGGAATGATGGTTGATTA
40 FMR4 GGCAACCAACCTATTCTT TCTTCCAGCAACTTATGATT
41 GAS5 TACTATCTGTCTGATGTATCTG GTTACCTGCTTACTTGGA
42 GDNFOS GGAAGAATAGAAGAACAACTCA TCATTGGTGGAACTGCTA
43 H19 CTCCACGACTCTGTTTCC TCTCCACAACTCCAACCA
44 HAR1A GCAGGATTGATTAATGATGTC TTATGGATAGCAAAGTTGACT
45 HAR1B TAGGATGTGAGATATAGG AGGATAGATGAATGAATG
46 HIF1A-AS1 CCATCCTCACAACAAGAA TCTGTATCTATCTGTCTGTCT
47 HLA-AS1 GGCTTGCTTAGTTGTTGA CTTCTTATGGTGTCCTCTTAC
48 HYMAI GCAGAGTTGAGTAGTTGT CATAATGTAATACCGTAGAAGAG
49 IL2RA TCCACTCACTCAATTCTCAA TCCTCCTCACCAACTTATG
50 IFNG-AS1 TGATTAAGTTGTGAGAGT TCCAAGACCTATGATATG
51 IGF2-AS CGCCACTGTGTTACCATT TTGCCCATCCCAGATAGAA
52 IPW GTAGCCTCTCCATAACTG TAATAGCCATCAACAACCT
53 KCNQ1DN CCCAGTCTCCTAATAAAG ACTTGTAACAGACATCAA
54 KCNQ1OT1 AATGCTGGAGAGGATGTG GTAGTGAGATTGCTGGATTATG
55 LINC00032 GTTGCTGGATGATGGATA ATTGTGGTAAGGTTAGAGTT
56 LINC00162 CCAATTCCAAGGATGTTGTGTT TCCGAGGTCTGGCTTCTA
57 LINC00271 GCAGGTTAGTTACATACG GGACAGCATTAGGAGATA
58 LSAMP-AS3 GTGTAAGTATTGGTAGTATGT CTGTAAGGAGGATGAAGA
59 MALAT1 CCGCTGCTATTAGAATGC CTTCAACAATCACTACTCCAA
60 MAP3K14 ATTATGTGGCATCAAGAAT ATGAGCAAGGTAGTAGAA
61 MEG3 TGGCATAGAGGAGGTGAT AGACAAGTAAGACAAGCAAGA
62 MESTIT1 TTATTATCTCGCTGATTCAC TGTCTTGTTGTCTCCATA
63 MIAT GCAGTCAGGATGTCAACC TAGGAGAGTGGCATAGTGTAG
64 MIR100HG GGAAGGCAATGTAGATGGT ACGAAGGAAGGATGGTAAC
65 MIR155HG AAGCACATCTATCCTCAA TCACATCTTCTTCCACAT
66 MIR17HG TTCTCTATGTGTCAATCCA ATAACCAACCATCCAACT
67 MKRN3-AS1 CCACATTAGGTAGTTCTG GAGTCTGAATCTTGAGTC
68 MYCNOS GGGAATGGTATTTGGAGTA GTTGTTGGTCTCTGTCTA
69 NAMA GAATGTGCGTGTATGTAG GCTTATGTAGTGCTAATGG
70 NEAT1 AAGTTCTTAGCCTGATGA TTAGCACAACACAATGAC
71 PCA3 GAATAGAGACAGGCACTA TGGATAGATGGATGGATAG
72 PCAT1 TAGAGCCTTGAAGATGAG TCGTGTAGTTGTAAGATGA
73 PCGEM1 TCACTCACTCACTCATTC TTATCTCTGTCATCATTAGGT
74 PDZRN3-AS1 TCAGCAGAATCATTAACG AACATCAGAGTCACCATA
75 PINC ATCTGTTATGGCAATCTG TCTGTCAACTAATGAATACC
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Table 2 (Continued)
ID LncRNA name Forward (5′ to 3′) Reverse (5′ to 3′)
76 PINK1-AS TCACGGTCTCAGTCATAA CCATCTTCATAGCCTACAC
77 PISRT1 GCAGTTACCTTAATGTTGAA GTGGTGTTGTTTGAGTATC
78 PRINS TAAGCAGAAGAGTGATAGA ACAGAGATAGAAGGACAG
79 PVT1 AACACTTACTCTCCTCTC AATACTATGATTCCACCTATAC
80 RMST GAAGGTAAGAGGCAGAGA ATTGTGAAGTCGGTAACG
81 RRP1B GTGATAGAGAATGGTGAT AGGAGTAGAAGTATGGAT
82 SCAANT1 TGAAACAAACCGAGAGAA TGAATGAATCACTTCCAGAA
83 SNHG11 CTTAGCCTCCTGTTATCA CCATCATCACACTTATTCAT
84 SNHG3 TAATCATTCTCAGAGCAATAG GCTTCCTACAGTTCACTA
85 SNHG4 TTGAAGATACCACATTACA AGATTGAGCCATTACATT
86 SNHG5 CCAGTGAAGATAATGAATGT ATTAGACCAATCAGACCTT
87 SOX2-OT TAGAAGCAGGAGTAAGAC ATATACACAGCAGATAATAGC
88 SPRY4-IT1 TCTGCTTTCTGATTCCAA TTTCATTTGTGAGGTTCTTT
89 SRA1 TTACAGAGATTAGAACCACATT GGCAAGTCAGAGTTACAAT
90 TCL6 CGCTTCAGTCATATACGA CTTACACAGGTCCATTCT
91 TDRG1 GATTCGTCTGGTTCCTTA TTCCTCTTGACTGATTCTAA
AACC
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94 U6 ATTGGA
.8. LncRNA PCR array
In this study, the lncRNA PCR Array was performed by Shanghai
uneng Biological Technology Co., Ltd. They used Bio-Rad 96PCR
lates containing 10L FastStart Universal SYBR® Green Master
nd 1L lncRNA primer mix, and the lncRNA PCR Array was per-
ormed according to the manufacturer’s protocol. We provided
erum samples of patients for this company. The primer sequences
f these lncRNAs were showed in Table 2.
.9. Statistic analysis
Data were expressed as mean± S.D, and statistical analysis was
erformedusingone-wayANOVA. Thedifferenceswere considered
obe statistical signiﬁcant forpvalue<0.05. Signiﬁcance levelswere
et at: *p<0.05, **p<0.01.
. Results
.1. TNF-˛ highly expressed in KD patientsEvidences have demonstrated that TNF- was overexpressed
n KD patients, and there was a positive correlation between the
egree of coronary arterial lesions and the concentration of TNF-
in KD patients. In this study, the ELISA and RT-PCR results also
ig. 1. TNF- highly expressed in KD patients. (A) The expression of TNF- in KD patien
atients and normal patients was detected by RT-PCR.CTAACTGAG TGAAAGTCAGCGAGAAAA
GCTCCATAA TCAATCTTCACAACAACACTAA
TACAGAGAAGATTA AATATGGAACGCTTCACGAAT
veriﬁed the concentration of TNF- in KD patients was higher than
normal patients (Fig. 1A and B). The results were consistent with
others study.
3.2. TNF-˛ induces HUVECs apoptosis
It is well known that TNF- is able to promote cell apoptosis.
In this study, we used HUVECs as cell model to explore the role
of TNF- on the apoptosis of vascular endothelial cell. The ﬂow
cytometry results showed that the apoptosis rate of HUVECs was
increases with the increased concentration of TNF- (Fig. 2A and
B). Also the western blot results further revealed the expression
of anti-apoptotic gene Bcl-2 was reduced and the expression of
apoptotic genecaspase-3wasenhanced in500ng/mlTNF- treated
group (Fig. 2C). Moreover, MTT test discovered that the prolifera-
tion of HUVECs was declined in 50ng/ml TNF- treated (p<0.05)
and 500ng/ml TNF- treated groups (p<0.01) compared to control
group on both day 1 day 3 (Fig. 2D). These results suggest TNF-
can induce HUVECs apoptosis.
3.3. LncRNA PINC overexpresses in TNF-˛ treated HUVECsIn order to explore the role of LncRNA in TNF- induc-
ing the apoptosis of HUVECs, we used lncRNA PCR array to
screen out the lncRNA which involved in this process. As
ts and normal patients was detected by ELISA. (B) The expression of TNF- in KD
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aig. 2. TNF- induces HUVECs apoptosis. (A and B) The apoptosis rate of HUVECs tr
xpression of Bcl-2, Caspase-3 and Bax in HUVECs treated with DMSO and 500ng/m
00ng/ml TNF- for 1 and 3 days respectively.
hown in Fig. 3, the expression of DAPK1, DNM3OS, DSCAM-
S1, IGF2-AS and PINC. Among these, PINC was signiﬁcantly
verexpressed in 500ng/ml TNF- treated HUVECs, the fold
hange exceed 800, thus we speculated that lncRNA PINC partic-
pated in the process of TNF- inducing vascular endothelial cell
poptosis.
Fig. 3. The screened out lncRNA PINC involved in the process of TNF- iwith DMSO, 50ng/ml and 500ng/ml TNF- respectively by ﬂow cytometry. (C) The
- respectively. (D) The proliferation of HUVECs treated with DMSO, 50ng/ml and
3.4. PINC overexpresses in KD patients
After we identiﬁed lncRNA PINC participated in the process of
TNF- inducing vascular endothelial cell apoptosis,we further veri-
ﬁed it in KD patients. As shown in Fig. 4, the expression of PINCwas
dramatically higher in KD patients than in normal patients. The
nducing vascular endothelial cell apoptosis by lncRNA PCR assay.
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Tig. 4. The expression of PINC was obvious higher in KD patients than in normal
atients by RT-PCR.
n vivo result was consistent with the above-mentioned in vitro
esult.
.5. Knockdown of PINC enhances the viability of HUVECs treated
ith TNF-˛
In order to further study the role of PINC in the process of
NF- inducing vascular endothelial cell apoptosis, we designed
wo siRNA of PINC. As shown in Fig. 5A, these siRNA could effec-
ively inhibit the expression of PINC, especially siRNA-2, so we
sed siRNA-2 for further study. Firstly, theMTT test results showed
hat the proliferation of HUVECs was reduced after treated with
00ng/ml TNF- on both day 1 and day 3 (p<0.05). Interestingly,
he proliferation of HUVECs was increased in siRNA+500ng/ml
NF- treated group compared to 500ng/ml TNF- treated group
n both day 1 and day 3 (p<0.05) (Fig. 5B). Moreover, the
ig. 5. The knockdown of PINC enhances the viability of HUVECs treated with TNF-. (
MSO, 500ng/ml TNF- and 500ng/ml TNF-+ siRNA-2 for 1, 3 days respectively. (C and
NF-+ siRNA-2 for 1 day.emistry & Cell Biology 72 (2016) 118–124 123
apoptosis of HUVECs was decreased in siRNA+500ng/ml TNF-
 treated group compared to 500ng/ml TNF- treated group
(p<0.05) (Fig. 5C and D).
3.6. The effects of knockdown of PINC on the expression of
anti-apoptotic and apoptotic gene
After silenced PINC in HUVECs, we detected the expression
of cyclin, apoptotic and anti-apoptotic gene. As RT-PCR results
showed, the expression of G1/S-speciﬁc-cyclin, cyclin-D1, was
reduced after treated with 500ng/ml TNF-. However it increased
when HUVECs treated with siRNA-2+500ng/ml TNF- compared
to 500ng/ml TNF- treated group. Moreover, the expression
of apoptotic gene, including caspase-3, caspase-7 and Bax, was
declined in siRNA-2+500ng/ml TNF- treated group compared to
500ng/ml TNF- treated group. Furthermore, the expression of
anti-apoptotic gene, including c-FLIP and Bcl-2, was enhanced in
siRNA-2+500ng/ml TNF- treated group compared to 500ng/ml
TNF- treated group (Fig. 6A). Similarly, the western blot results
showed, the expressionof Baxandcaspase-3was reduced in siRNA-
2+500ng/ml TNF- treated group compared to 500ng/ml TNF-
treated group. And the expression of Bcl-XL (anti-apoptotic) was
increased in siRNA-2+500ng/ml TNF- treated group compared
to 500ng/ml TNF- treated group (Fig. 6B).
4. Discussion
Noncoding RNAs (ncRNAs) are coming into view as impor-
tant players in the signaling pathway of cells, and contend the
protein-coding counterparts. Increased evidences have indicated
the functional diversity of ncRNAs, in particular long noncoding
RNAs (lncRNAs), and their relevance in regulating disease and
development (Amaral and Mattick, 2008; Huarte and Rinn, 2010;
Pauli et al., 2011;Wapinski and Chang, 2011). The previous studies
to explore the role of ncRNAs have mainly focused on small/short
A) Knockdown of PINC in HUVECs. (B) The proliferation of HUVECs treated with
D) The apoptosis of HUVECs treated with DMSO, 500ng/ml TNF- and 500ng/ml
124 C. Jiang et al. / The International Journal of Bioch
Fig. 6. The effects of knockdown of PINC on the expression of anti-apoptotic and
apoptotic gene. (A) The expression of cyclin D1, caspase-3, c-FLIP, caspase-7, Bcl-2
and bax in HUVECs treated with DMSO, 500ng/ml TNF- and 500ng/ml TNF-
+ siRNA-2 respectively by RT-PCR. (B) The expression of Cyclin D1, Caspase-3,
C-ﬂip, Caspase-7, Bcl-2, Bax in HUVECs treated with DMSO, 500ng/ml TNF- and
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Tan, Z., Yuan, Y., Chen, S., Chen, Y., Chen, T.X., 2013. Plasma endothelial
microparticles, TNF-a and IL-6 in Kawasaki disease. Indian Pediatr. 50,00ng/ml TNF-+ siRNA-2 respectively by Western Blot.
NAs (<200 nucleotides). However, in the past few years there has
een an increased focus on lncRNAs, as large-scale analyses have
evealed the abundance of lncRNAs in more complex organisms
Ewan et al., 2007; Gough et al., 2005; Paul et al., 2004). In this
tudy, we found lncRNA PINC involved in the development of KD.
PINC (pregnancy induced noncoding RNA) is a long non-coding
NA. Itwas originally identiﬁed in themammary glands of estrogen
nd progesterone-treated rats (Ginger et al., 2001). PINC may be a
ammal-speciﬁc gene. It is conserved in a number of mammalian
enomes (human,mouse, rat, chimpanzee, dog, cowandopossum),
ut not in fugu, zebraﬁsh or xenopus genomes (Ginger et al., 2006).
oreover it may have a role in cell survival and in the regulation of
ell cycle progression (Ginger et al., 2006). Similarly, in this study
e revealed PINC was able to effect on the viability of vascular
ndothelial cells.
KD is a systemic vascular inﬂammatory disease, and it is accom-
aniedbyoverexpressedTNF- inKDpatients. It iswell known that
NF- can induce inﬂammatory response and highly expressed in
nﬂamed tissue. In this study, we also found the expression of TNF-
in KD patients was signiﬁcant higher than normal patients, it is
onsistent with others studies. Moreover, others previous studies
eported TNF- can induce cell apoptosis (Filippatos et al., 2004;
spina et al., 2003). We demonstrated that TNF-was able to pro-
ote vascular endothelial cells apoptosis, it may further damage
lood vessels in KD patients. Furthermore, we found PINC was
igniﬁcantly overexpressed in TNF- treated HUVECs, so we spec-
lated that PINC involved in the process of TNF- inducing vascular
ndothelial cells apoptosis.We further veriﬁed PINCoverexpressed
n KD patients, thus the in vivo results consisted with the in vitro
esults. Besides after silenced the expression of PINC inHUVECs,we
ound the viability of HUVECs treated with TNF- was enhanced,emistry & Cell Biology 72 (2016) 118–124
and the expression of anti-apoptotic gene was increased and the
expression of apoptotic gene was reduced.
In summary, we discovered PINC have an important role in vas-
cular endothelial cells’ survival, highly expressed PINC in vascular
endothelial cells is contributed to cells apoptosis. TNF- induces
vascular endothelial cells apoptosis can through overexpressing
PINC, thus inhibition of PINC expression may conduce to prevent
and treat the KD.
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